Muscle Strength
Conditions
Interventions
The study will be a randomized, double-blind, placebo-controlled clinical trial.
The study was carried out in a randomized, double-blind, double-blind, randomized, double-blind, randomized, double-bli
absolute error of 0.05
test power of 0.95 and considering two measures and two groups, totalizing a sample of 40 people, being 20 per group.
The study population will be composed of adult and elderly male patients with a co
Dietary supplement
G07.203.300.456
Sponsors
Jessika Soares
Faculdade de Nutrição
Eligibility
Sex/Gender
Male
Age
59 Years to 80 Years
Inclusion criteria
Inclusion criteria: Diagnosis of cancer of the esophagus, stomach, pancreas or biliary tract, attended at the oncology clinic of the hospital; in exclusive chemotherapy; decrease or deficit in food intake; with nutritional risk, evidence of fat loss and / or muscle mass, not receiving a protein supplement enriched with leucine or other branched-chain amino acids, not participating in any muscle strengthening program that agrees to participate voluntarily.
Exclusion criteria
Exclusion criteria: Patients without nutritional risk; presence of edema; mental disorders; cognitive or walking disability; use of pacemakers or metal parts in the body; with use of enteral therapy and / or total parenteral nutrition; absorptive dysfunctions; obstruction of digestive access and use of protein supplementation prior to study or during recruitment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight gain through increased body mass index, with statistical difference <0.05;Gain muscle mass through bioimpedance, with statistical difference <0.05 | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of the quality of life and functional capacity, by increasing the score, with statistical difference <0.05 | — |
Countries
Brazil
Contacts
Public ContactJéssika;Jéssika Pereira Soares;Soares
Faculdade de Nutrição ;Faculdade de Nutrição
Outcome results
None listed